Assignee
MESOBLAST INT SARL
CH·29 granted patents·38 pending applications·143 citations·filing 2013–2025
Top patents by PatentIndex Score
67 records- 0197US10960025B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2020·Granted Mar 30, 2021·5 cites·14 claims
- 0297US10828334B1Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2020·Granted Nov 10, 2020·5 cites·30 claims
- 0397US10716814B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Jul 21, 2020·10 cites·22 claims
- 0496US10729727B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Aug 4, 2020·7 cites·23 claims
- 0596US10550369B2Enhanced MSC preparationMESOBLAST INT SARL·Filed 2018·Granted Feb 4, 2020·19 cites·20 claims
- 0695US11389484B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Jul 19, 2022·4 cites·19 claims
- 0795US10668101B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2013·Granted Jun 2, 2020·10 cites·17 claims
- 0895US9963678B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2015·Granted May 8, 2018·17 cites·11 claims
- 0994US9943547B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2013·Granted Apr 17, 2018·14 cites·21 claims
- 1094US9828586B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2013·Granted Nov 28, 2017·20 cites·19 claims
- 1193US11821004B2Mesenchymal stem cells expressing TNF-α receptorsMESOBLAST INT SARL·Filed 2020·Granted Nov 21, 2023·3 cites·13 claims
- 1293US10400218B2Stem cell compositionMESOBLAST INT SARL·Filed 2015·Granted Sep 3, 2019·11 cites·8 claims
- 1391US2026035666A1Enhanced msc preparationsMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 1489US12115194B2Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2022·Granted Oct 15, 2024·1 cites·13 claims
- 1588US10624930B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2015·Granted Apr 21, 2020·5 cites·19 claims
- 1686US11491188B2Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2015·Granted Nov 8, 2022·3 cites·16 claims
- 1785US12410405B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 1885US11708560B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2019·Granted Jul 25, 2023·2 cites·7 claims
- 1985US2025129337A1Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2024·Application pending·0 cites
- 2084US2023076630A1Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 2184US2024301356A1Mesenchymal stem cells expressing tnf-alpha receptorsMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 2283US12215352B2Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2023·Granted Feb 4, 2025·0 cites·10 claims
- 2382US12257270B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2022·Granted Mar 25, 2025·0 cites·10 claims
- 2481US9814580B2Joint repair using mesenchymal stem cellsMESOBLAST INT SARL·Filed 2015·Granted Nov 14, 2017·3 cites·22 claims
- 2578US11795435B2Potency assayMESOBLAST INT SARL·Filed 2016·Granted Oct 24, 2023·2 cites·11 claims
- 2678US2025064858A1Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2024·Application pending·0 cites
- 2777US12303536B2Method for treating heart failureMESOBLAST INT SARL·Filed 2023·Granted May 20, 2025·0 cites·14 claims
- 2877US11242506B2Methods and apparatus for separating cells from microcarriersMESOBLAST INT SARL·Filed 2016·Granted Feb 8, 2022·2 cites·10 claims
- 2977US2023030428A1Stem cell compositionMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 3075US11312941B2Stem cell compositionMESOBLAST INT SARL·Filed 2019·Granted Apr 26, 2022·0 cites·7 claims
- 3175US2023089901A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 3274US2025312379A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3374US2024076621A1Potency assayMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 3472US11685899B2Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2019·Granted Jun 27, 2023·0 cites·11 claims
- 3572US11406669B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2020·Granted Aug 9, 2022·0 cites·20 claims
- 3672US2025136944A1Stem cell compositionMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3772US2025319134A1Treatment of immune disordersMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3870US2025249043A1Method for treating heart failureMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3969US2026069635A1Mesenchymal progenitor cells for enhancing partial reprogramming of target cellsMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 4069US2020197444A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2019·Application pending·0 cites
- 4167US2024207323A1Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4267US2024197787A1Method for treating acute respiratory distress syndrome (ards) in specific patients using mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4362US2018087032A1Mesenchymal stem cells expressing tnf-alpha receptorsMESOBLAST INT SARL·Filed 2017·Application pending·0 cites
- 4462US2025032552A1Method of treating severe graft versus host diseaseMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4562US2025319428A1High flow filter and method of useMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 4660US2023220349A13d culture of mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 4759US2023293590A1Cellular compositions and methods of treatmentMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 4859US2025090589A1Method of treating progressive heart failure in subjects at high risk of poor outcomesMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4959US2023097931A1Method for treating chronic graft versus host diseaseMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 5058US2018037867A1Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2016·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →